Dennis Koop
Overview
Explore the profile of Dennis Koop including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
152
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Togioka B, Zarnegarnia Y, Bleyle L, Koop D, Brookfield K, Yanez N, et al.
Anesth Analg
. 2022 May;
135(4):777-786.
PMID: 35544759
Background: Intraperitoneal chloroprocaine has been used during cesarean delivery to supplement suboptimal neuraxial anesthesia for decades. The short in vitro half-life of chloroprocaine (11-21 seconds) has been cited to support...
2.
Moss M, Bushlin I, Kazmierczak S, Koop D, Hendrickson R, Zuckerman K, et al.
Pediatr Res
. 2021 Jan;
90(4):861-868.
PMID: 33469174
Background: Information on cannabinoids in breast milk and maternal cannabis use is limited. We quantified cannabinoids in plasma and breast milk of breastfeeding mothers and assessed cannabis use patterns. Methods:...
3.
Cameron M, Taylor C, Lapidus J, Ramsey K, Koop D, Spain R
J Clin Pharmacol
. 2020 Mar;
60(8):1099-1106.
PMID: 32212340
We compared the gastrointestinal (GI) tolerability and assessed for bioequivalent absorption of R-lipoic acid (LA) in people with progressive multiple sclerosis (MS) in a single-center, double-blind, randomized crossover trial. Participants...
4.
Bittner F, Murchison C, Koop D, Bourdette D, Spain R
Neurol Neuroimmunol Neuroinflamm
. 2017 Jul;
4(5):e380.
PMID: 28680918
No abstract available.
5.
Lovera J, Ramos A, Devier D, Garrison V, Kovner B, Reza T, et al.
J Neurol Sci
. 2015 Aug;
358(1-2):46-52.
PMID: 26298797
Objectives: Phase I (PhI): assess the safety of Polyphenon E in people with multiple sclerosis (MS) and determine the futility of Polyphenon E as a neuroprotective agent. Correlate plasma levels...
6.
Edelman A, Munar M, Elman M, Koop D, Cherala G
Br J Clin Pharmacol
. 2012 Feb;
74(3):510-4.
PMID: 22299599
Aim(s): While it is known that CYP3A4/5 activity is decreased with combined oral contraceptive (COC) use and obesity suppresses CYP expression, the combined effects of obesity and COC use on...
7.
Koerner I, Jacks R, DeBarber A, Koop D, Mao P, Grant D, et al.
J Neurosci
. 2007 Apr;
27(17):4642-9.
PMID: 17460077
Single nucleotide polymorphisms (SNPs) in the human EPHX2 gene have recently been implicated in susceptibility to cardiovascular disease, including stroke. EPHX2 encodes for soluble epoxide hydrolase (sEH), an important enzyme...
8.
Lakshman R, Cederbaum A, Hoek J, Konishi M, Koop D, Donohu T
Alcohol Clin Exp Res
. 2005 Oct;
29(9):1726-34.
PMID: 16205373
This article represents the proceedings of a symposium at the 2004 RSA Meeting held in Vancouver, Canada. The chairs were Arthur I. Cederbaum and Raj Lakshman. The presentations were (1)...
9.
Yang M, Deng Q, Chen S, Xiong S, Koop D, Tsukamoto H
Hepatol Res
. 2005 Aug;
32(4):202-12.
PMID: 16107322
Background And Aims: : A herbal prescription, Yan-gan-wan (YGW), has been known to offer hepatoprotective effects in Asian countries for years. This study investigated its mechanisms of action. Methods: :...
10.
Wadsworth T, Poonyagariyagorn H, Sullivan E, Koop D, Roselli C
J Pharmacol Exp Ther
. 2003 Apr;
306(1):187-94.
PMID: 12676889
PC-SPES, a proprietary mixture composed of eight different herbs, is used worldwide as an alternative treatment by prostate cancer patients. It has been suggested that the clinical and in vitro...